JP2018520090A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018520090A5 JP2018520090A5 JP2017555688A JP2017555688A JP2018520090A5 JP 2018520090 A5 JP2018520090 A5 JP 2018520090A5 JP 2017555688 A JP2017555688 A JP 2017555688A JP 2017555688 A JP2017555688 A JP 2017555688A JP 2018520090 A5 JP2018520090 A5 JP 2018520090A5
- Authority
- JP
- Japan
- Prior art keywords
- injury
- site
- composition
- composition according
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000006378 damage Effects 0.000 claims description 32
- 208000027418 Wounds and injury Diseases 0.000 claims description 31
- 208000014674 injury Diseases 0.000 claims description 31
- 230000017423 tissue regeneration Effects 0.000 claims description 30
- 239000011573 trace mineral Substances 0.000 claims description 30
- 235000013619 trace mineral Nutrition 0.000 claims description 30
- 230000001939 inductive effect Effects 0.000 claims description 19
- 210000000130 stem cell Anatomy 0.000 claims description 14
- 208000037816 tissue injury Diseases 0.000 claims description 13
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 10
- 230000001771 impaired effect Effects 0.000 claims description 10
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 8
- 229910052802 copper Inorganic materials 0.000 claims description 8
- 239000010949 copper Substances 0.000 claims description 8
- 238000002347 injection Methods 0.000 claims description 8
- 239000007924 injection Substances 0.000 claims description 8
- 239000007943 implant Substances 0.000 claims description 6
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 5
- 229910052742 iron Inorganic materials 0.000 claims description 5
- 239000011669 selenium Substances 0.000 claims description 5
- 229910052711 selenium Inorganic materials 0.000 claims description 5
- 239000011701 zinc Substances 0.000 claims description 5
- 229910052725 zinc Inorganic materials 0.000 claims description 5
- 239000000411 inducer Substances 0.000 claims description 4
- 210000001519 tissue Anatomy 0.000 claims description 4
- 210000001185 bone marrow Anatomy 0.000 claims description 3
- 210000004556 brain Anatomy 0.000 claims description 3
- 210000004027 cell Anatomy 0.000 claims description 3
- 230000001684 chronic effect Effects 0.000 claims description 3
- 230000002950 deficient Effects 0.000 claims description 3
- 210000002216 heart Anatomy 0.000 claims description 3
- 210000004185 liver Anatomy 0.000 claims description 3
- 230000005012 migration Effects 0.000 claims description 3
- 238000013508 migration Methods 0.000 claims description 3
- 210000001719 neurosecretory cell Anatomy 0.000 claims description 3
- 210000002027 skeletal muscle Anatomy 0.000 claims description 3
- 230000001154 acute effect Effects 0.000 claims description 2
- 210000004204 blood vessel Anatomy 0.000 claims description 2
- 230000009172 bursting Effects 0.000 claims description 2
- 230000012010 growth Effects 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 2
- 238000002604 ultrasonography Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 31
- 210000005013 brain tissue Anatomy 0.000 claims 3
- 238000002513 implantation Methods 0.000 claims 2
- 238000001990 intravenous administration Methods 0.000 claims 1
- 230000000451 tissue damage Effects 0.000 claims 1
- 231100000827 tissue damage Toxicity 0.000 claims 1
- 238000000034 method Methods 0.000 description 42
- 230000012292 cell migration Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2015/077136 WO2016168993A1 (en) | 2015-04-22 | 2015-04-22 | Methods of tissue repair and regeneration |
| CNPCT/CN2015/077136 | 2015-04-22 | ||
| PCT/CN2016/078873 WO2016169416A1 (en) | 2015-04-22 | 2016-04-08 | Methods of tissue repair and regeneration |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020097590A Division JP2020143158A (ja) | 2015-04-22 | 2020-06-04 | 組織の修復及び再生の方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018520090A JP2018520090A (ja) | 2018-07-26 |
| JP2018520090A5 true JP2018520090A5 (enExample) | 2019-05-16 |
| JP6895388B2 JP6895388B2 (ja) | 2021-06-30 |
Family
ID=57142823
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017555688A Active JP6895388B2 (ja) | 2015-04-22 | 2016-04-08 | 組織の修復及び再生の方法 |
| JP2020097590A Pending JP2020143158A (ja) | 2015-04-22 | 2020-06-04 | 組織の修復及び再生の方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020097590A Pending JP2020143158A (ja) | 2015-04-22 | 2020-06-04 | 組織の修復及び再生の方法 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US11077138B2 (enExample) |
| EP (1) | EP3285782B1 (enExample) |
| JP (2) | JP6895388B2 (enExample) |
| KR (2) | KR20170137919A (enExample) |
| CN (1) | CN107921062B (enExample) |
| AU (1) | AU2016250971B2 (enExample) |
| BR (1) | BR112017022355A2 (enExample) |
| CA (1) | CA2982840C (enExample) |
| CL (1) | CL2017002600A1 (enExample) |
| CO (1) | CO2017010382A2 (enExample) |
| DK (1) | DK3285782T3 (enExample) |
| EA (1) | EA038598B1 (enExample) |
| EC (1) | ECSP17068922A (enExample) |
| ES (1) | ES2898655T3 (enExample) |
| HK (1) | HK1251181A1 (enExample) |
| HU (1) | HUE056650T2 (enExample) |
| IL (1) | IL255116B (enExample) |
| MX (1) | MX2017013122A (enExample) |
| MY (1) | MY189322A (enExample) |
| NZ (1) | NZ736516A (enExample) |
| PE (1) | PE20180240A1 (enExample) |
| SG (1) | SG11201708431QA (enExample) |
| TW (1) | TWI702956B (enExample) |
| UA (1) | UA124332C2 (enExample) |
| WO (2) | WO2016168993A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016168993A1 (en) | 2015-04-22 | 2016-10-27 | Innolife Co., Ltd. | Methods of tissue repair and regeneration |
| WO2017049529A1 (en) | 2015-09-24 | 2017-03-30 | Innolife Co., Ltd. | A pharmaceutical composition comprising a copper chelating tetramine and the use thereof |
| CN106754662B (zh) * | 2016-11-21 | 2019-11-12 | 中国人民解放军军事医学科学院基础医学研究所 | 心肌细胞的制备方法 |
| TWI615127B (zh) * | 2017-01-17 | 2018-02-21 | 正崴精密工業股份有限公司 | 計算血壓的方法及其裝置 |
| WO2018217710A1 (en) * | 2017-05-22 | 2018-11-29 | The Regents Of The University Of California | Micro/nanobubble solutions for tissue preservation and generation thereof |
| TWI635469B (zh) * | 2017-08-29 | 2018-09-11 | 國立臺北商業大學 | 用於反應力訓練的電腦程式產品 |
| TWI634528B (zh) * | 2017-08-29 | 2018-09-01 | 國立臺北商業大學 | 用於評估認知能力的電腦程式產品 |
| KR102121417B1 (ko) * | 2018-10-08 | 2020-06-10 | 가천대학교 산학협력단 | Stat3 활성화제를 이용한 골격근세포 분화 유도용 조성물 및 이를 이용한 골격근세포 분화 유도 방법 |
| US12285182B2 (en) | 2018-10-10 | 2025-04-29 | Innova Vascular, Inc. | Devices and methods for removing an embolus |
| CN109513037B (zh) * | 2018-11-14 | 2021-09-17 | 华中科技大学同济医学院附属协和医院 | 一种负载介孔生物玻璃的小肠粘膜下层创面敷料 |
| US20220176011A1 (en) * | 2019-02-18 | 2022-06-09 | Lankenau Institute For Medical Research | Scar reducing wound closure materials |
| CN110288581B (zh) * | 2019-06-26 | 2022-11-04 | 电子科技大学 | 一种基于保持形状凸性水平集模型的分割方法 |
| US20220347188A1 (en) * | 2019-06-27 | 2022-11-03 | Friedrich Miescher Insitute For Biomedical Research | Promoting tissue regeneration |
| CN111297895A (zh) * | 2020-02-20 | 2020-06-19 | 成都因诺生物医药科技有限公司 | 用于治疗动脉粥样硬化的组合物的制药用途 |
| EP4267201A4 (en) * | 2020-12-22 | 2024-11-20 | Fluidx Medical Technology, Inc. | In situsolidifying injectable compositions with transient contrast agents and methods of making and using thereof |
| US20240366183A1 (en) * | 2021-09-08 | 2024-11-07 | The Board Of Trustees Of The University Of Illinois | Real-time super-resolution ultrasound microvessel imaging and velocimetry |
| CN114010163B (zh) * | 2021-12-02 | 2023-12-19 | 中国中医科学院医学实验中心 | 基于光学成像的表皮细胞迁移定位系统及方法 |
| CN114469897B (zh) * | 2022-01-12 | 2023-02-28 | 上海市胸科医院 | 靶向治疗心肌梗死的锂皂石复合递送材料及其制备与应用 |
| CN115177786A (zh) * | 2022-07-14 | 2022-10-14 | 山东大学 | 一种原位负载蒙脱土/纳米羟基磷灰石的壳聚糖复合支架材料及其制备方法 |
| WO2024237752A1 (ko) * | 2023-05-12 | 2024-11-21 | 국립해양생물자원관 | 다중구리 산화효소 펩타이드 및 이로부터 유래된 펩타이드를 포함하는 상처 치유 또는 피부 재생용 조성물 |
| CN117547554B (zh) * | 2024-01-12 | 2024-05-14 | 山东康根源生物集团有限公司 | 一种间充质干细胞修复制剂及其制备方法 |
| CN118879625A (zh) * | 2024-07-24 | 2024-11-01 | 南方医科大学珠江医院 | 一种硫化铜工程化干细胞外泌体的制备方法及其应用 |
| TWI924567B (zh) * | 2025-07-31 | 2026-05-01 | 明志科技大學 | 結合α-酮戊二酸之聚離胺酸奈米羥基磷灰石及其用途 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5580575A (en) | 1989-12-22 | 1996-12-03 | Imarx Pharmaceutical Corp. | Therapeutic drug delivery systems |
| JPH03297475A (ja) * | 1990-04-16 | 1991-12-27 | Ken Ishihara | 共振音波により薬物の放出を制御する方法 |
| US5558082A (en) | 1995-01-09 | 1996-09-24 | Spencer; Robert F. | Method of intubating a patient and introducer for use with such method |
| ATE248511T1 (de) | 1996-03-12 | 2003-09-15 | Univ Nebraska | Zusammensetzung zur zielortspezifischen verabreichung eines medikamentes und verfahren zur anwendung |
| US6896659B2 (en) | 1998-02-06 | 2005-05-24 | Point Biomedical Corporation | Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility |
| GB9826658D0 (en) | 1998-12-03 | 1999-01-27 | Univ London | Tissue repair |
| SK16182003A3 (sk) * | 2001-06-12 | 2004-05-04 | Cellomeda Oy | Porézny hubovitý celulózový materiál na ošetrenie zranení |
| US20060100278A1 (en) * | 2002-08-20 | 2006-05-11 | Cooper Garth J S | Dosage forms and related therapies |
| CN1688301A (zh) | 2002-08-20 | 2005-10-26 | 普罗特米克斯公司 | 药物剂型及相关的治疗用途 |
| NZ555072A (en) | 2004-11-07 | 2010-09-30 | Cupron Corp | Copper containing materials for treating wounds, burns and other skin conditions |
| US20070048387A1 (en) * | 2005-09-01 | 2007-03-01 | Edwards Jeffrey D | Tissue disruption treatment and composition for use thereof |
| HUE036745T2 (hu) | 2006-11-03 | 2018-07-30 | Multiple Sclerosis Res Center Of New York | Csontvelõ eredetû mesenchimális õssejtek, mint a neurális progenitor sejtek forrásai |
| US8287896B2 (en) * | 2010-01-06 | 2012-10-16 | The Curators Of The University Of Missouri | Scaffolds with trace element for tissue regeneration in mammals |
| EP2453844B1 (en) * | 2009-07-16 | 2020-09-02 | The Curators Of The University Of Missouri | Scaffolds with trace element for tissue regeneration in mammals |
| US8481066B2 (en) | 2009-07-16 | 2013-07-09 | The Curators Of The University Of Missouri | Scaffold for tissue regeneration in mammals |
| CN101926821B (zh) * | 2010-07-12 | 2012-01-25 | 四川大学华西医院 | 一种靶向释放微量元素的药物组合物及制备方法和应用 |
| CN102302507B (zh) * | 2010-07-12 | 2014-02-05 | 四川大学华西医院 | 定向控释微量元素的药物组合物及制备方法和应用 |
| CN103502218B (zh) | 2011-03-04 | 2016-08-17 | 生命科技公司 | 用于缀合生物分子的化合物和方法 |
| JP5598864B2 (ja) | 2011-12-05 | 2014-10-01 | 北海道公立大学法人 札幌医科大学 | 細胞増殖方法ならびに組織の修復および再生のための医薬 |
| CN103467578B (zh) * | 2012-06-08 | 2015-07-08 | 四川大学华西医院 | 一种短肽、载铜纳米生物材料及在制备治疗脑梗死的药物中的应用 |
| WO2014027474A1 (ja) * | 2012-08-17 | 2014-02-20 | 株式会社Ｃｌｉｏ | 心筋梗塞の修復再生を誘導する多能性幹細胞 |
| KR101628586B1 (ko) | 2012-08-28 | 2016-06-08 | (주)오리지날 바이오메디칼스 | 킬레이트 복합 교질입자로 구성된 의약 조성물의 제어방출방법 |
| WO2014132262A1 (en) | 2013-02-28 | 2014-09-04 | Ramot At Tel-Aviv University Ltd. | Peptide-based hydrogel particles and uses thereof |
| CN105753719B (zh) | 2014-12-17 | 2019-06-21 | 四川科瑞德凯华制药有限公司 | 一种盐酸曲恩汀化合物 |
| WO2016168993A1 (en) | 2015-04-22 | 2016-10-27 | Innolife Co., Ltd. | Methods of tissue repair and regeneration |
| WO2017049529A1 (en) | 2015-09-24 | 2017-03-30 | Innolife Co., Ltd. | A pharmaceutical composition comprising a copper chelating tetramine and the use thereof |
-
2015
- 2015-04-22 WO PCT/CN2015/077136 patent/WO2016168993A1/en not_active Ceased
-
2016
- 2016-04-08 HU HUE16782563A patent/HUE056650T2/hu unknown
- 2016-04-08 MY MYPI2017703903A patent/MY189322A/en unknown
- 2016-04-08 KR KR1020177033507A patent/KR20170137919A/ko not_active Ceased
- 2016-04-08 WO PCT/CN2016/078873 patent/WO2016169416A1/en not_active Ceased
- 2016-04-08 UA UAA201711249A patent/UA124332C2/uk unknown
- 2016-04-08 MX MX2017013122A patent/MX2017013122A/es unknown
- 2016-04-08 NZ NZ736516A patent/NZ736516A/en unknown
- 2016-04-08 EA EA201792307A patent/EA038598B1/ru unknown
- 2016-04-08 JP JP2017555688A patent/JP6895388B2/ja active Active
- 2016-04-08 DK DK16782563.7T patent/DK3285782T3/da active
- 2016-04-08 PE PE2017002201A patent/PE20180240A1/es unknown
- 2016-04-08 BR BR112017022355A patent/BR112017022355A2/pt not_active Application Discontinuation
- 2016-04-08 US US15/568,386 patent/US11077138B2/en active Active
- 2016-04-08 CN CN201680029765.5A patent/CN107921062B/zh active Active
- 2016-04-08 AU AU2016250971A patent/AU2016250971B2/en active Active
- 2016-04-08 CA CA2982840A patent/CA2982840C/en active Active
- 2016-04-08 ES ES16782563T patent/ES2898655T3/es active Active
- 2016-04-08 SG SG11201708431QA patent/SG11201708431QA/en unknown
- 2016-04-08 EP EP16782563.7A patent/EP3285782B1/en active Active
- 2016-04-08 KR KR1020197037851A patent/KR102347010B1/ko active Active
- 2016-04-08 HK HK18110758.1A patent/HK1251181A1/zh unknown
- 2016-04-21 TW TW105112419A patent/TWI702956B/zh active
-
2017
- 2017-10-11 CO CONC2017/0010382A patent/CO2017010382A2/es unknown
- 2017-10-13 CL CL2017002600A patent/CL2017002600A1/es unknown
- 2017-10-17 EC ECIEPI201768922A patent/ECSP17068922A/es unknown
- 2017-10-18 IL IL255116A patent/IL255116B/en active IP Right Grant
-
2020
- 2020-06-04 JP JP2020097590A patent/JP2020143158A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3490605B1 (en) | Replacement of cytotoxic preconditioning before cellular immunotherapy | |
| Fiers | Tumor necrosis factor characterization at the molecular, cellular and in vivo level | |
| JP2020040969A5 (enExample) | ||
| ES2511791T3 (es) | Células madre mesenquimales positivas para ABCB5 como moduladoras de inmunidad | |
| US10993919B2 (en) | Chondroprotective nanoparticles for the treatment of osteoarthritis | |
| JP2019059744A (ja) | リンパ組織に幹細胞および前駆細胞が結合することを阻害する組成および方法、ならびにリンパ組織の胚中心を再生させるための組成および方法 | |
| ES2769778T3 (es) | Composiciones inmunomoduladoras | |
| US10580262B2 (en) | Eluting matrix and uses thereof | |
| ES2661236T3 (es) | Procedimientos, sistemas y composiciones para administración de microARN derivado de células/a base de vesículas | |
| AU2013404939A1 (en) | Eluting matrix and uses thereof | |
| BR112016009753B1 (pt) | Métodos in vitro de cultura de amostras de células estromais mesenquimais e para a preparação de células estromais mesenquimais | |
| Lee et al. | In situ tissue regeneration: host cell recruitment and biomaterial design | |
| Byun et al. | Development of a composite hydrogel incorporating anti-inflammatory and osteoinductive nanoparticles for effective bone regeneration | |
| WO2021003300A1 (en) | Mesenchymal stem cells or stromal cells harboring modified rnas encoding vegf and bmp polypeptides | |
| JP2021514003A5 (enExample) | ||
| Song et al. | The immunomodulatory effects of DNA-conjugated collagen scaffolds on bone healing | |
| US20200276007A1 (en) | Multilayered biologic mesh and methods of use thereof | |
| JP2017529396A5 (enExample) | ||
| Khodanovich et al. | Effect of fluoxetine on neurogenesis in hippocampal dentate gyrus after global transient cerebral ischemia in rats | |
| US20090047241A1 (en) | Il-12 facilitates both the recovery of endogenous hematopoiesis and the engraftment of stem cells after ionizing radiation | |
| EP3323411B1 (en) | Composition for inhibiting angiogenesis containing nanoparticle-vitreous body-based protein complex as active ingredient, and use thereof | |
| Li et al. | Beneficial effects of non-matched allogeneic cord blood mononuclear cells upon patients with idiopathic osteoporosis | |
| TWI731944B (zh) | 移植病患之治療 | |
| JP6977979B2 (ja) | 神経損傷治療又は予防用医薬 | |
| Sussman et al. | A focused review of clinical and preclinical studies of cell-based therapies in stroke |